Bank of New York Mellon
EXAS

Bank of New York Mellon’s Exact Sciences EXAS Stock Holding History

Bank of New York Mellon’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-620,376
Closed -$63M – 4234
2025
Q4 		$63M Sell
620,376
-17,507
-3% -$1.41M 0.01% 869
2025
Q3 		$34.9M Buy
637,883
+29,919
+5% +$1.49M 0.01% 1227
2025
Q2 		$32.3M Sell
607,964
-197,654
-25% -$10M 0.01% 1253
2025
Q1 		$34.9M Sell
805,618
-12,490
-2% -$633K 0.01% 1185
2024
Q4 		$46M Buy
818,108
+5,348
+0.7% +$333K 0.01% 1077
2024
Q3 		$55.4M Buy
812,760
+27,737
+4% +$1.57M 0.01% 966
2024
Q2 		$33.2M Buy
785,023
+31,665
+4% +$1.74M 0.01% 1275
2024
Q1 		$52M Sell
753,358
-92,028
-11% -$5.82M 0.01% 1017
2023
Q4 		$62.5M Buy
845,386
+15,632
+2% +$1.02M 0.01% 905
2023
Q3 		$56.6M Sell
829,754
-6,543
-0.8% -$555K 0.01% 903
2023
Q2 		$78.5M Sell
836,297
-6,005
-0.7% -$468K 0.02% 755
2023
Q1 		$57.1M Sell
842,302
-5,489
-0.6% -$353K 0.01% 925
2022
Q4 		$42M Sell
847,791
-6,025
-0.7% -$246K 0.01% 1109
2022
Q3 		$27.7M Buy
853,816
+146,348
+21% +$6.03M 0.01% 1301
2022
Q2 		$27.9M Buy
707,468
+93,917
+15% +$5.02M 0.01% 1345
2022
Q1 		$42.9M Buy
613,551
+3,978
+0.7% +$291K 0.01% 1200
2021
Q4 		$47.4M Sell
609,573
-9,745
-2% -$860K 0.01% 1208
2021
Q3 		$59.1M Sell
619,318
-9,812
-2% -$1.04M 0.01% 1027
2021
Q2 		$78.2M Buy
629,130
+50,167
+9% +$5.99M 0.02% 844
2021
Q1 		$76.3M Sell
578,963
-27,075
-4% -$3.71M 0.02% 836
2020
Q4 		$80.3M Buy
606,038
+20,770
+4% +$2.51M 0.02% 759
2020
Q3 		$59.7M Sell
585,268
-12,125
-2% -$1.05M 0.01% 811
2020
Q2 		$51.9M Sell
597,393
-64,901
-10% -$5.19M 0.01% 861
2020
Q1 		$38.4M Sell
662,294
-331,728
-33% -$26.9M 0.01% 899
2019
Q4 		$91.9M Buy
994,022
+30,423
+3% +$2.67M 0.02% 636
2019
Q3 		$87.1M Sell
963,599
-136,134
-12% -$15.5M 0.02% 643
2019
Q2 		$130M Buy
1,099,733
+151,649
+16% +$15.3M 0.04% 487
2019
Q1 		$82.1M Sell
948,084
-47,494
-5% -$4.04M 0.02% 689
2018
Q4 		$62.8M Sell
995,578
-199,005
-17% -$13.7M 0.02% 758
2018
Q3 		$94.3M Sell
1,194,583
-335,612
-22% -$21.9M 0.02% 647
2018
Q2 		$91.5M Sell
1,530,195
-33,220
-2% -$1.79M 0.02% 633
2018
Q1 		$63.1M Buy
1,563,415
+938,855
+150% +$45.8M 0.02% 849
2017
Q4 		$32.8M Sell
624,560
-37,377
-6% -$2M 0.01% 1267
2017
Q3 		$31.2M Buy
661,937
+45,792
+7% +$1.84M 0.01% 1290
2017
Q2 		$21.8M Sell
616,145
-30,613
-5% -$945K 0.01% 1499
2017
Q1 		$15.3M Buy
646,758
+158,347
+32% +$3.14M ﹤0.01% 1719
2016
Q4 		$6.53M Buy
488,411
+21,684
+5% +$350K ﹤0.01% 2181
2016
Q3 		$8.67M Buy
466,727
+32,497
+7% +$573K ﹤0.01% 1950
2016
Q2 		$5.32M Sell
434,230
-16,398
-4% -$124K ﹤0.01% 2179
2016
Q1 		$3.04M Sell
450,628
-21,364
-5% -$137K ﹤0.01% 2427
2015
Q4 		$4.36M Sell
471,992
-94,497
-17% -$879K ﹤0.01% 2300
2015
Q3 		$10.2M Sell
566,489
-76,706
-12% -$1.76M ﹤0.01% 1853
2015
Q2 		$19.1M Buy
643,195
+11,318
+2% +$284K 0.01% 1517
2015
Q1 		$13.9M Buy
631,877
+17,923
+3% +$455K ﹤0.01% 1748
2014
Q4 		$16.8M Buy
613,954
+98,210
+19% +$2.39M ﹤0.01% 1592
2014
Q3 		$9.99M Buy
515,744
+47,749
+10% +$875K ﹤0.01% 1896
2014
Q2 		$7.97M Buy
467,995
+69,971
+18% +$963K ﹤0.01% 2061
2014
Q1 		$5.64M Sell
398,024
-11,849
-3% -$160K ﹤0.01% 2251
2013
Q4 		$4.82M Buy
409,873
+41,159
+11% +$472K ﹤0.01% 2316
2013
Q3 		$4.35M Sell
368,714
-7,785
-2% -$99.9K ﹤0.01% 2325
2013
Q2 		$5.24M Buy
+376,499
New +$4.09M ﹤0.01% 2167

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Bank of New York Mellon's EXAS Position: Q1 2026 in Review

Bank of New York Mellon sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 620,376 shares — an estimated $63M sold.

Bank of New York Mellon first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $130M in Q2 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Bank of New York Mellon reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Bank of New York Mellon sold 620,376 Exact Sciences shares in Q1 2026, an estimated $63M.
  • Bank of New York Mellon first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • Bank of New York Mellon's Exact Sciences position peaked at $130M in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Bank of New York Mellon's 13F filing for Q1 2026, filed 5 May 2026.